ohsu

Researchers Outline Epigenetics, Possible End of Chronic Disease

Kent L. Thornburg, a pioneer in the field of epigenetics at the Knight Cardiovascular Institute at Oregon Health & Science University, told the Oregon Women’s Health Network at the kickoff of its 2015 lecture series “it is likely most chronic disease can disappear over time”

“We’ve come to believe chronic disease is inevitable. There’s a lot of evidence against that point of view,” Kent Thornburg told the Women’s Health Network. “We need to stop people from being vulnerable to disease.”

OHSU requests $77.3 million from state general fund

Operating income fell $10 million during the past six months but still on target to match levels of recent years, according to results presented at board of directors meeting.

When the state legislative assembly convenes Monday for its 2015 session, don’t expect the Oregon Health & Science University to make any waves.

OHSU Knight Cardiovascular Institute, Edwards Lifesciences launch knowledge exchange between engineers and cardiologists

Inspired by famous partnership between Starr and Edwards, the Starr Educational Training Program will continue tradition of collaboration in cardiovascular innovation

PORTLAND, Ore. – The OHSU Knight Cardiovascular Institute and Edwards Lifesciences, the global leader in the science of heart valves and hemodynamic monitoring, today announced the launch of the Starr Educational Training Program, a technical training program that provides medical device engineer

Pharmaceutical Companies Gave Millions of Dollars to Oregon Physicians

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

Research Centers Eli Lilly was the largest contributor followed by Pfizer, GlaxoSmithKline with and Merck in this comprehensive analysis conducted by ProPublica, an independent, non-profit newsroom that produces investigative journalism in the public interest. The Lund Report extrapolated the Oregon data to present these latest findings.

Pharmaceutical companies handed out at least $40.7 million to Oregon physicians and healthcare institutions between 2009 and 2003.Undoubtedly, this figure does not represent all of the money, according to ProPublica because of the voluntary participation.

Which Oregon Hospital Has the Toughest Time Preventing Infections?

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

A CDC database on hospital infections can tell us a lot. What it says about one of the biggest medical systems in the state may be surprising.

What's the safest hospital in Oregon? What about the least safe? And how do we even figure that out?

OHSU Fined $2.4 Million by CMS

The hospital, which has refunded the overpayments, resulted from the lack of adequate controls when billing Medicare claims.

An audit conducted by the Office of Inspector General has found that Oregon Health & Science University did not fully comply with Medicare billing requirements from 2010 through 2012 which resulted in overpayments of $2.4 million.

Pages

Subscribe to ohsu